GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: DS-7300 | I-DXd
Compound class:
Antibody
Comment: Ifinatamab deruxtecan (DS-7300) is a B7-H3 (CD276)-targeting antibody-drug conjugate (ADC) [1]. B7-H3 is an immuno-oncology molecular target in solid tumours. The deruxtecan conjugate is a camptothecin derivative that is used as a cytotoxic DNA topoisomerase 1 payload.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11954 | ifinatamab deruxtecan |
Synonyms ![]() |
| DS-7300 | I-DXd |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1256 |
| Other databases | |
| GtoPdb PubChem SID | 513757535 |
| Search PubMed clinical trials | ifinatamab deruxtecan |
| Search PubMed titles | ifinatamab deruxtecan |
| Search PubMed titles/abstracts | ifinatamab deruxtecan |